Cargando…

Impaired migratory phenotype of CD4(+) T cells in Parkinson’s disease

Dysfunctions in the immune system appear implicated in both disease onset and progression of Parkinson’s disease (PD). Neurodegeneration observed in the brain of PD patients has been associated with neuroinflammation that is linked to alterations in peripheral adaptive immunity, where CD4(+) T cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamula, Dejan, Khosousi, Shervin, He, Yachao, Lazarevic, Vesna, Svenningsson, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741605/ https://www.ncbi.nlm.nih.gov/pubmed/36496415 http://dx.doi.org/10.1038/s41531-022-00438-0

Ejemplares similares

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson’s Disease
por: Green, Holly F., et al.
Publicado: (2019)

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson’s disease
por: Paslawski, Wojciech, et al.
Publicado: (2023)

Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson’s disease and Lewy body dementia
por: Asghar, Muhammad, et al.
Publicado: (2022)

Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents
por: He, Yachao, et al.
Publicado: (2023)

Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex
por: Lazarevic, Vesna, et al.
Publicado: (2019)

Ketamine decreases neuronally released glutamate via retrograde stimulation of presynaptic adenosine A1 receptors
por: Lazarevic, Vesna, et al.
Publicado: (2021)

α-Synuclein induced cholesterol lowering increases tonic and reduces depolarization-evoked synaptic vesicle recycling and glutamate release
por: Lazarevic, Vesna, et al.
Publicado: (2022)

Vertical saccades and antisaccades: complementary markers for motor and cognitive impairment in Parkinson’s disease
por: Waldthaler, Josefine, et al.
Publicado: (2019)

Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
por: Kaya, Ibrahim, et al.
Publicado: (2023)

Novel Treatment Opportunities Against Cognitive Impairment in Parkinson’s Disease with an Emphasis on Diabetes-Related Pathways
por: Green, Holly, et al.
Publicado: (2019)

Decreased Prosaposin and Progranulin in the Cingulate Cortex Are Associated with Schizophrenia Pathophysiology
por: He, Yachao, et al.
Publicado: (2022)

Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson’s Disease
por: Wallin, Johan, et al.
Publicado: (2021)

High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort
por: Fazio, Patrik, et al.
Publicado: (2020)

Antidepressant-like properties of sarizotan in experimental Parkinsonism
por: Zhang, Xiaoqun, et al.
Publicado: (2011)

Cortex-wide topography of 1/f-exponent in Parkinson’s disease
por: Helson, Pascal, et al.
Publicado: (2023)

24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
por: Björkhem, Ingemar, et al.
Publicado: (2018)

Genetically Targeted Clinical Trials in Parkinson’s Disease: Learning from the Successes Made in Oncology
por: Sjögren, Magnus, et al.
Publicado: (2021)

Acquisition of New Migratory Properties by Highly Differentiated CD4+CD28(null) T Lymphocytes in Rheumatoid Arthritis Disease
por: Rioseras, Beatriz, et al.
Publicado: (2021)

Pupil light reflex dynamics in Parkinson’s disease
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

Does Information from the Parkinson KinetiGraph™ (PKG) Influence the Neurologist’s Treatment Decisions?—An Observational Study in Routine Clinical Care of People with Parkinson’s Disease
por: Sundgren, Mathias, et al.
Publicado: (2021)

CD271 determines migratory properties of melanoma cells
por: Radke, Josefine, et al.
Publicado: (2017)

c-Met enforces proinflammatory and migratory features of human activated CD4(+) T cells
por: Benkhoucha, Mahdia, et al.
Publicado: (2021)

Reading Alterations in Parkinson's Disease Indicate Worse Cognitive Status
por: Tsitsi, Panagiota, et al.
Publicado: (2023)

The frequency of somatic mutations in cancer predicts the phenotypic relevance of germline mutations
por: Draetta, Edoardo Luigi, et al.
Publicado: (2023)

The relationships between mild cognitive impairment and phenotype in Parkinson’s disease
por: Szeto, Jennifer YY, et al.
Publicado: (2015)

Expanding the ataxia with oculomotor apraxia type 4 phenotype
por: Paucar, Martin, et al.
Publicado: (2016)

Targeting the Nerve Growth Factor Signaling Impairs the Proliferative and Migratory Phenotype of Triple-Negative Breast Cancer Cells
por: Di Donato, Marzia, et al.
Publicado: (2021)

COPD monocytes demonstrate impaired migratory ability
por: Ravi, Arjun K, et al.
Publicado: (2017)

Fixation Duration and Pupil Size as Diagnostic Tools in Parkinson’s Disease
por: Tsitsi, Panagiota, et al.
Publicado: (2021)

Phenotypically sorted highly and weakly migratory triple negative breast cancer cells exhibit migratory and metastatic commensalism
por: Hapach, Lauren A., et al.
Publicado: (2023)

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder
por: Svenningsson, Per, et al.
Publicado: (2017)

CD4(+)NKG2D(+) T Cells Exhibit Enhanced Migratory and Encephalitogenic Properties in Neuroinflammation
por: Ruck, Tobias, et al.
Publicado: (2013)

Migratory Properties of Naive, Effector, and Memory Cd8(+) T Cells
por: Weninger, Wolfgang, et al.
Publicado: (2001)

Synaptic proteins in CSF relate to Parkinson’s disease stage markers
por: Bereczki, Erika, et al.
Publicado: (2017)

Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2016)

Polygenic discrimination of migratory phenotypes in an estuarine forage fish
por: Campbell, Matthew A, et al.
Publicado: (2022)

Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease
por: Jaiteh, Mariama, et al.
Publicado: (2018)

Saccadic Impairments in Patients with the Norrbottnian Form of Gaucher’s Disease Type 3
por: Blume, Josefine, et al.
Publicado: (2017)

MCEE Mutations in an Adult Patient with Parkinson’s Disease, Dementia, Stroke and Elevated Levels of Methylmalonic Acid
por: Andréasson, Mattias, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2iremnet3bth29hvf87amsflb2